✦ LIBER ✦

Antiplatelet drugs in secondary prevention of stroke, lessons from the European Stroke Prevention Studies 1 and 2

✍ Scribed by J Sivenius; M Laakso; PJ Riekkinen Sr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary prevention of myocardial infar

✍ A. Lowenthal 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Antiplatelet therapy is effective in the

✍ J. Sivenius; P. J. Riekkinen; H. Kilpeläinen; M. Laakso; I. Penttilä 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Lessons from MATCH for future randomised

✍ Peter M Rothwell 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 585 KB

Cost-Effectiveness of Antiplatelet Agent

✍ David B. Matchar; Gregory P. Samsa; Suping Liu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Efficacy of Drug Therapy in the Secondar

✍ Gerald F. Fletcher; Vincent Bufalino; Fernando Costa; Larry B. Goldstein; Dan Jo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Secondary prevention in the acute and ea

✍ H. C. Diener; R. Weber; C. Weimar; J. Röther 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB